These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36437904)

  • 1. Modeling the impact of child vaccination (5-11 y) on overall COVID-19 related hospitalizations and mortality in a context of omicron variant predominance and different vaccination coverage paces in Brazil.
    Müller GC; Ferreira LS; Mesias Campos FE; Borges ME; Berg de Almeida G; Poloni S; Simon LM; Bagattini ÂM; Quarti M; Felizola Diniz Filho JA; Kraenkel RA; Coutinho RM; Camey SA; Kuchenbecker RS; Toscano CM
    Lancet Reg Health Am; 2023 Jan; 17():100396. PubMed ID: 36437904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.
    Mendes D; Chapman R; Gal P; Atwell J; Nguyen JL; Hamson L; Di Fusco M; Czudek C; Yang J
    J Med Econ; 2022; 25(1):1039-1050. PubMed ID: 36097853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study.
    Borchering RK; Mullany LC; Howerton E; Chinazzi M; Smith CP; Qin M; Reich NG; Contamin L; Levander J; Kerr J; Espino J; Hochheiser H; Lovett K; Kinsey M; Tallaksen K; Wilson S; Shin L; Lemaitre JC; Hulse JD; Kaminsky J; Lee EC; Davis JT; Mu K; Xiong X; Piontti APY; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Hurt B; Chen J; Mortveit H; Wilson A; Marathe M; Hoops S; Bhattacharya P; Machi D; Chen S; Paul R; Janies D; Thill JC; Galanti M; Yamana T; Pei S; Shaman J; Espana G; Cavany S; Moore S; Perkins A; Healy JM; Slayton RB; Johansson MA; Biggerstaff M; Shea K; Truelove SA; Runge MC; Viboud C; Lessler J
    medRxiv; 2022 Mar; ():. PubMed ID: 35313593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study.
    Borchering RK; Mullany LC; Howerton E; Chinazzi M; Smith CP; Qin M; Reich NG; Contamin L; Levander J; Kerr J; Espino J; Hochheiser H; Lovett K; Kinsey M; Tallaksen K; Wilson S; Shin L; Lemaitre JC; Hulse JD; Kaminsky J; Lee EC; Hill AL; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Hurt B; Chen J; Mortveit H; Wilson A; Marathe M; Hoops S; Bhattacharya P; Machi D; Chen S; Paul R; Janies D; Thill JC; Galanti M; Yamana T; Pei S; Shaman J; España G; Cavany S; Moore S; Perkins A; Healy JM; Slayton RB; Johansson MA; Biggerstaff M; Shea K; Truelove SA; Runge MC; Viboud C; Lessler J
    Lancet Reg Health Am; 2023 Jan; 17():100398. PubMed ID: 36437905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia.
    Thakkar K; Spinardi J; Kyaw MH; Yang J; Mendoza CF; Dass M; Law W; Ozbilgili E; Yarnoff B
    Expert Rev Vaccines; 2023; 22(1):714-725. PubMed ID: 37548520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage.
    Martins-Filho PR; de Souza Araújo AA; Quintans-Júnior LJ; Soares BDS; Barboza WS; Cavalcante TF; Santos VS
    Epidemiol Health; 2022; 44():e2022036. PubMed ID: 35413166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling Hub.
    Jung SM; Loo SL; Howerton E; Contamin L; Smith CP; Carcelén EC; Yan K; Bents SJ; Levander J; Espino J; Lemaitre JC; Sato K; McKee CD; Hill AL; Chinazzi M; Davis JT; Mu K; Vespignani A; Rosenstrom ET; Rodriguez-Cartes SA; Ivy JS; Mayorga ME; Swann JL; España G; Cavany S; Moore SM; Perkins A; Chen S; Paul R; Janies D; Thill JC; Srivastava A; Al Aawar M; Bi K; Bandekar SR; Bouchnita A; Fox SJ; Meyers LA; Porebski P; Venkatramanan S; Adiga A; Hurt B; Klahn B; Outten J; Chen J; Mortveit H; Wilson A; Hoops S; Bhattacharya P; Machi D; Vullikanti A; Lewis B; Marathe M; Hochheiser H; Runge MC; Shea K; Truelove S; Viboud C; Lessler J
    medRxiv; 2023 Nov; ():. PubMed ID: 37961207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the pattern of COVID-19 hospitalizations and deaths after substantial vaccination of the elderly in Manaus, Amazonas State, Brazil].
    Orellana JDY; Cunha GMD; Marrero L; Leite IDC; Domingues CMAS; Horta BL
    Cad Saude Publica; 2022; 38(5):PT192321. PubMed ID: 35584432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Ferdinands JM; Rao S; Dixon BE; Mitchell PK; DeSilva MB; Irving SA; Lewis N; Natarajan K; Stenehjem E; Grannis SJ; Han J; McEvoy C; Ong TC; Naleway AL; Reese SE; Embi PJ; Dascomb K; Klein NP; Griggs EP; Konatham D; Kharbanda AB; Yang DH; Fadel WF; Grisel N; Goddard K; Patel P; Liao IC; Birch R; Valvi NR; Reynolds S; Arndorfer J; Zerbo O; Dickerson M; Murthy K; Williams J; Bozio CH; Blanton L; Verani JR; Schrag SJ; Dalton AF; Wondimu MH; Link-Gelles R; Azziz-Baumgartner E; Barron MA; Gaglani M; Thompson MG; Fireman B
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):255-263. PubMed ID: 35176007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance.
    Mendes D; Chapman R; Aruffo E; Gal P; Nguyen JL; Hamson L; Di Fusco M; Czudek C; Yang J
    Expert Rev Vaccines; 2023; 22(1):90-103. PubMed ID: 36519401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving vaccination coverage and offering vaccine to all school-age children allowed uninterrupted in-person schooling in King County, WA: Modeling analysis.
    Bracis C; Moore M; Swan DA; Matrajt L; Anderson L; Reeves DB; Burns E; Schiffer JT; Dimitrov D
    Math Biosci Eng; 2022 Apr; 19(6):5699-5716. PubMed ID: 35603374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
    Castelli JM; Rearte A; Olszevicki S; Voto C; Del Valle Juarez M; Pesce M; Iovane AN; Paz M; Chaparro ME; Buyayisqui MP; Markiewicz MB; Landoni M; Giovacchini CM; Vizzotti C
    BMJ; 2022 Nov; 379():e073070. PubMed ID: 36450402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
    Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
    Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.